The next leg of the U.S. semiconductor trade may not be only about AI-chip speed. It may also be about who already has manufacturing capacity on American soil. Texas Instruments (Nasdaq: TXN), Intel (Nasdaq: INTC), and Qorvo (Nasdaq: QRVO), trading at $294.19, $102.62, and $89.48, respectively, stand out after KeyBanc recently highlighted them as leading U.S.-listed semiconductor names by domestic manufacturing footprint.
CHIPS Act incentives, tariff shifts, and a national security push to reshore wafer output have hardened into balance-sheet items.
TXN pulled in $850M in Q2 CHIPS incentives. Intel is ramping 18A high-volume manufacturing in Arizona and Oregon, backed by a US government equity stake and a $5B NVIDIA investment related to AI infrastructure. Qorvo keeps a large share of its RF production stateside while preparing to merge with Skyworks.
Reshoring Is Turning Into Real Revenue
The demand backdrop is wider than AI alone. Texas Instruments posted Q2 revenue of $5.46 billion, up 22.8% year over year, with EPS of $2.14 beating estimates by 10.56%, led by industrial, data center, and automotive demand. Intel’s Data Center & AI segment grew 22% last quarter, while Intel Foundry rose 16%, and non-GAAP EPS of $0.29 cleared a $0.01 estimate.
Qorvo’s High Performance Analog unit grew 7.9%, with a 34.7% GAAP operating margin, while FY2026 free cash flow rose 40.2% to roughly $680 million. The takeaway is that customers are paying up for domestic and diversified supply chains as Asia exposure becomes harder to ignore.
The Prices Already Reflect a Lot
Texas Instruments trades at 38 times forward earnings after a 69.5% YTD run, putting the stock well above its historical valuation band, even as capex is down 60.6% year over year and the factory buildout phase cools. Intel has surged 178.1% YTD and 341.57% over one year, but trailing earnings remain negative, the forward P/E sits near 119, and Foundry losses are still part of the story. Qorvo brings its own caveats: revenue declined 1.1% in FY2026, an $82.4 million goodwill impairment hit Q4, guidance remains suspended, and Apple concentration is still a structural risk.
Cycles Cut Both Ways
Semiconductors remain cyclical, tariff and export rules can shift overnight, and Intel’s turnaround still depends on Foundry hitting yield milestones. Qorvo’s story also hinges on the Skyworks deal closing. Investors who want confirmation could wait for Q3 earnings reports, Intel 18A volume data, and regulatory clearance on the merger before adding.
What the Street Sees Right Now
TXN’s analyst target sits at $303.59 against $294.19, with 2 Strong Buy, 15 Buy, 17 Hold, and 2 Sell ratings. Intel’s target is $106.70 versus $102.62, with 2 Strong Buy, 11 Buy, 32 Hold, 2 Sell, and 2 Strong Sell. Qorvo’s $91.46 target sits just above $89.48, with 1 Strong Buy, 2 Buy, 16 Hold, and 1 Sell. Targets are just one data point. TXN and INTC have run far ahead of the S&P 500 year to date; Qorvo, up 5.88%, has lagged the broader index by a wide margin.
Why the Trio Stands Out at These Prices
At $294.19, $102.62, and $89.48, Texas Instruments, Intel, and Qorvo look well-positioned for the reshoring cycle. Here is why.
The reshoring wave is showing up in Texas Instruments’ revenue mix, Intel’s selection as the host CPU for NVIDIA’s DGX Rubin NVL8 and its multi-year Google custom ASIC partnership, and Qorvo’s expanding margins. Texas Instruments offers the cleanest exposure at a premium price, backed by an already-built U.S. fab base, $6.53 billion in TTM free cash flow, and quarterly CHIPS Act inflows.
Intel is the highest-risk, highest-conviction play. A U.S. government equity stake, NVIDIA’s investment, the Terafab consortium with SpaceX, xAI, and Tesla, and the 18A ramp are all converging inside the same 12-month window. Qorvo is the value angle, priced near merger-arb levels, with CEO Bob Bruggeworth targeting FY2027 non-GAAP EPS approaching $7.00.
All three offer distinct exposure to the American-made chips theme for investors who view reshoring as a decade-long shift, not a headline cycle.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks